The DOI matches its Crossref record; 106 of the 108 references it cites were found in a registry or an index.
Nanoparticle therapeutics: an emerging treatment modality for cancer
Abstract
Nanoparticles--particles in the size range 1-100 nm--are emerging as a class of therapeutics for cancer. Early clinical results suggest that nanoparticle therapeutics can show enhanced efficacy, while simultaneously reducing side effects, owing to properties such as more targeted localization in tumours and active cellular uptake. Here, we highlight the features of nanoparticle therapeutics that distinguish them from previous anticancer therapies, and describe how these features provide the potential for therapeutic effects that are not achievable with other modalities. While large numbers of preclinical studies have been published, the emphasis here is placed on preclinical and clinical studies that are likely to affect clinical investigations and their implications for advancing the treatment of patients with cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using cell membranes and EVs as carriers in nanomedicine offers significant advantages, including exceptional biological compatibility, biodegradability, and a superior drug-loading performance.”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [189]
In the citing paper
“Additionally, nanopharmaceuticals derived from cell membranes and their byproducts naturally contain targeting ability, making them especially promising for the research and development of drug transport systems in lymphoma treatment.”
From Emerging role of exosomes in cancer therapy: progress and challenges (2025) · cites this paper as [189]
In the citing paper
“Immobilization of an enzyme on the surface of nanoparticles can increase enzyme stability (31), and we therefore developed DNase I-coated nanoparticles.”
From Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps (2016) · cites this paper as [31]
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Multidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,978
Self-citationMechanisms of Cancer Drug Resistance
Gottesman, M. M. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103929 · Cited by 2,643
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201
Self-citationGradishar, W. J., Tjulandin, S., Davidson, N. G. P., Shaw, H., Desai, N. P., Bhar, P., Hawkins, M., & O’Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,159
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1958 · Cited by 1,956
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature reviews. Cancer · doi:10.1038/nrc903 · Cited by 1,648
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,129
Flagged first, then by citations
2 of the 108 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Kurtzberg, J., Moore, J. O. Scudiery, D. & Franklin, A. A phase II study of polyethylene glycol (PEG) conjugated L-asparaginase in patients with refractory acute leukaemias. Proc. Am. Assoc. Cancer Res. 29, 213 (1988).
- Socinski, M. & Ramalingham, S. XYOTAX in NSCLC and other solid tumors. Emerging evidence on biological differences between men and women: is gender-specific therapy warranted? Chemotherapy Foundation web site [online], (2005).
- Vasey, P. et al. Phase I clinical and pharmacokinetic study of PKI (HPMA copolymer doxorubicin) first member of a new class of chemotherapeutics agents: drug–polymer conjugates. Clin. Cancer Res. 5, 83–94 (1999).
Cited by
Sorted by citations
Items 301–400 of 1,023
Applications of vectorized gold nanoparticles to the diagnosis and therapy of cancer
Llevot, A., & Astruc, D. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15080d · Cited by 281
Glutathione responsive polymers and their application in drug delivery systems
Quinn, J. F., Whittaker, M. R., & Davis, T. P. (2016) · Polymer Chemistry · doi:10.1039/c6py01365a · Cited by 282
The Ever-Expanding Myokinome: Discovery Challenges and Therapeutic Implications
Whitham, M., & Febbraio, M. A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.153 · Cited by 279
Low-Temperature Photothermal Therapy: Strategies and Applications
Yi, X., Duan, Q., & Wu, F. (2021) · Research · doi:10.34133/2021/9816594 · Cited by 282
Advanced Photoacoustic Imaging Applications of Near‐Infrared Absorbing Organic Nanoparticles
Jiang, Y., & Pu, K. (2017) · Small · doi:10.1002/smll.201700710 · Cited by 279
Zhu, X., Li, J., Qiu, X., Liu, Y., Feng, W., & Li, F. (2018) · Nature Communications · doi:10.1038/s41467-018-04571-4 · Cited by 277
Zhang, Q., Wang, X., Li, P., Nguyen, K. T., Wang, X., Luo, Z. Y., Zhang, H., Tan, N. S., & Zhao, Y. (2013) · Advanced Functional Materials · doi:10.1002/adfm.201302988 · Cited by 276
She, W., Luo, K., Zhang, C., Wang, G., Geng, Y., Li, L., He, B., & Gu, Z. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.007 · Cited by 275
He, C., Liu, D., & Lin, W. (2015) · ACS Nano · doi:10.1021/nn506963h · Cited by 274
The chemistry and biology of vanadium compounds in cancer therapeutics
Kioseoglou, E., Petanidis, S., Gabriel, C., & Salifoglou, A. (2015) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2015.03.010 · Cited by 273
Chang, B., Sha, X., Guo, J., Jiao, Y., Wang, C., & Yang, W. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm10631g · Cited by 273
Li, X., Qian, Y., Liu, T., Hu, X., Zhang, G., You, Y., & Liu, S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.049 · Cited by 271
Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery
Baeza, A., Colilla, M., & Vallet‐Regí, M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.953051 · Cited by 274
Jiang, X., Xin, H., Ren, Q., Gu, J., Zhu, L., Du, F., Feng, C., Xie, Y., Sha, X., & Fang, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.094 · Cited by 274
Visualization of the Cellular Uptake and Trafficking of DNA Origami Nanostructures in Cancer Cells
Wang, P., Rahman, M. A., Zhao, Z., Weiss, K., Zhang, C., Chen, Z., Hurwitz, S. J., Chen, Z. G., Shin, D. M., & Ke, Y. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b09024 · Cited by 269
Self-citationNair, H. B. B., Sung, B., Yadav, V. R., Kannappan, R., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.021 · Cited by 273
Wang, S., Chen, K., Wu, T., Wang, H., Lin, W., Ohashi, M., Chiou, P.-Y. E., & Tseng, H. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000062 · Cited by 272
pH-Responsive Capsules Engineered from Metal-Phenolic Networks for Anticancer Drug Delivery
Yuan, P., Guo, J., Ejima, H., Chen, X., Richardson, J. J., Sun, H., & Caruso, F. (2015) · Small · doi:10.1002/smll.201403343 · Cited by 269
Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research
Egusquiaguirre, S. P., Igartúa, M., Hernández, R. M., & Pedraz, J. L. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0766-6 · Cited by 270
Multimodal drug delivery using gold nanoparticles
Kim, C., Ghosh, P., & Rotello, V. M. (2009) · Nanoscale · doi:10.1039/b9nr00112c · Cited by 266
Enhancing cell therapies from the outside in: Cell surface engineering using synthetic nanomaterials
Stephan, M. T., & Irvine, D. J. (2011) · Nano Today · doi:10.1016/j.nantod.2011.04.001 · Cited by 270
Advances in Platinum Chemotherapeutics
Harper, B. W. J., Krause‐Heuer, A. M., Grant, M. P., Manohar, M., Garbutcheon‐Singh, K. B., & Aldrich-Wright, J. R. (2010) · Chemistry - A European Journal · doi:10.1002/chem.201000148 · Cited by 267
Zhu, L., Zhou, Z., Mao, H. Z., & Yang, L. P. H. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0316 · Cited by 268
Fluorescence Manipulation by Gold Nanoparticles: From Complete Quenching to Extensive Enhancement
Kang, K. A., Wang, J., Jasinski, J. B., & Achilefu, S. A. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-16 · Cited by 265
Recent progress on nanoparticle-based drug delivery systems for cancer therapy
Xin, Y., Yin, M., Zhao, L., Meng, F., & Luo, L. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2017.0052 · Cited by 250
Multifunctional Bismuth Selenide Nanocomposites for Antitumor Thermo-Chemotherapy and Imaging
Li, Z., Hu, Y., Howard, K. A., Jiang, T., Fan, X., Miao, Z., Sun, Y., Besenbacher, F., & Yu, M. (2015) · ACS Nano · doi:10.1021/acsnano.5b06259 · Cited by 264
Rosenholm, J. M., Mamaeva, V., Sahlgren, C., & Lindén, M. (2011) · Nanomedicine · doi:10.2217/nnm.11.166 · Cited by 263
Supramolecular Photothermal Nanomaterials as an Emerging Paradigm toward Precision Cancer Therapy
Zhao, L., Liu, Y., Chang, R., Xing, R., & Yan, X. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201806877 · Cited by 263
Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting
Murakami, M., Cabral, H., Matsumoto, Y., Wu, S., Kano, M. R., Yamori, T., Nishiyama, N., & Kataoka, K. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001385 · Cited by 263
Exocytosis of nanoparticles from cells: Role in cellular retention and toxicity
Sakhtianchi, R., Minchin, R. F., Lee, K., Alkilany, A. M., Serpooshan, V., & Mahmoudi, M. (2013) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2013.10.013 · Cited by 271
Synergistic nanomedicine by combined gene and photothermal therapy
Kim, J., Kim, J., Jeong, C., & Kim, W. J. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.018 · Cited by 264
pH‐Dependent Anticancer Drug Release from Silk Nanoparticles
Seib, F. P., Jones, G. T., Rnjak‐Kovacina, J., Lin, Y., & Kaplan, D. L. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300034 · Cited by 261
Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects
Khan, H. Z., Ullah, H., Martorell, M., Valdés, S. C. E., Belwal, T., Tejada, S., Sureda, A., & Kamal, M. A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.023 · Cited by 265
Duan, X., Chan, C., Han, W., Guo, N., Weichselbaum, R. R., & Lin, W. (2019) · Nature Communications · doi:10.1038/s41467-019-09221-x · Cited by 256
Kuthati, Y., Kankala, R. K., & Lee, C. (2015) · Applied Clay Science · doi:10.1016/j.clay.2015.04.018 · Cited by 258
Evolution in Lithography Techniques: Microlithography to Nanolithography
Sharma, E., Rathi, R., Misharwal, J., Sinhmar, B., Kumari, S., Dalal, J., & Kumar, A. (2022) · Nanomaterials · doi:10.3390/nano12162754 · Cited by 257
She, W., Li, N., Luo, K., Guo, C., Wang, G., Geng, Y., & Gu, Z. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.017 · Cited by 257
Jiang, C., Cheng, H., Yuan, A., Tang, X., Wu, J., & Hu, Y. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.11.041 · Cited by 256
Yu, G., Yu, S. P., Saha, M. L., Zhou, J., Cook, T. R., Yung, B. C., Chen, J., Mao, Z., Zhang, F., Zhou, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06574-7 · Cited by 256
Emerging Nanotechnology Approaches for HIV/AIDS Treatment and Prevention
Mamo, T., Moseman, E. A., Kolishetti, N., Salvador-Morales, C., Shi, J., Kuritzkes, D. R., Langer, R., von Andrian, U. H., & Farokhzad, O. C. (2010) · Nanomedicine · doi:10.2217/nnm.10.1 · Cited by 258
Engineering Nanocomposite Materials for Cancer Therapy
Minelli, C., Lowe, S. B., & Stevens, M. M. (2010) · Small · doi:10.1002/smll.201000523 · Cited by 255
Potential of plant proteins for medical applications
Reddy, N., & Yang, Y. (2011) · Trends in biotechnology · doi:10.1016/j.tibtech.2011.05.003 · Cited by 255
Nanoparticle-Based Delivery Systems for Vaccines
Bezbaruah, R., Chavda, V. P., Nongrang, L., Alom, S., Deka, K., Kalita, T., Ali, F., Bhattacharjee, B., & Vora, L. K. (2022) · Vaccines · doi:10.3390/vaccines10111946 · Cited by 276
Yu, H., Cui, Z., Yu, P., Guo, C., Feng, B., Jiang, T., Wang, S., Yin, Q., Zhong, D., Yang, X., et al. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201404484 · Cited by 253
Vitamin E-based nanomedicines for anti-cancer drug delivery
Duhem, N., Danhier, F., & Véronique Préat, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.009 · Cited by 253
Spatiotemporal controlled delivery of nanoparticles to injured vasculature
Chan, J. M., Zhang, L., Tong, R., Ghosh, D., Gao, W., Liao, G., Yuet, K. P., Gray, D. S., Rhee, J., Cheng, J., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914585107 · Cited by 260
Liu, D., Poon, C. J., Lu, K., He, C., & Lin, W. (2014) · Nature Communications · doi:10.1038/ncomms5182 · Cited by 251
Renfrew, A. K. (2014) · Metallomics · doi:10.1039/c4mt00069b · Cited by 252
Wang, C., Sun, X., Cheng, L., Yin, S., Yang, G., Li, Y., & Liu, Z. (2014) · Advanced Materials · doi:10.1002/adma.201400158 · Cited by 252
Nanomedicines for renal disease: current status and future applications
Kamaly, N., He, C., Ausiello, D. A., & Farokhzad, O. C. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.156 · Cited by 256
Different strategies to overcome multidrug resistance in cancer
Manju, S., & Gong, S. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.06.004 · Cited by 259
Intracellular drug release nanosystems
Meng, F., Cheng, R., Deng, C., & Zhong, Z. (2012) · Materials Today · doi:10.1016/s1369-7021(12)70195-5 · Cited by 250
Mesoporous Silica Nanoparticles for Protein Protection and Delivery
Xu, C., Lei, C., & Yu, C. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00290 · Cited by 247
Nanotheranostics for personalized medicine
Mura, S., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.006 · Cited by 568
Hydrogel Containing Nanoparticle-Stabilized Liposomes for Topical Antimicrobial Delivery
Gao, W., Vecchio, D. A., Li, J., Zhu, J., Zhang, Q., Fu, V., Li, J., Thamphiwatana, S., Lu, D., & Zhang, L. (2014) · ACS Nano · doi:10.1021/nn500110a · Cited by 251
Therapeutic Enzyme‐Responsive Nanoparticles for Targeted Delivery and Accumulation in Tumors
Callmann, C. E., Barback, C. V., Thompson, M. P., Hall, D. J., Mattrey, R. F., & Gianneschi, N. C. (2015) · Advanced Materials · doi:10.1002/adma.201501803 · Cited by 249
Zheng, M., Zhao, P., Luo, Z., Gong, P., Zheng, C., Zhang, P., Yue, C., Gao, D., Ma, Y., & Cai, L. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am5004393 · Cited by 249
Luk, B. T., Fang, R. H., Hu, C. J., Copp, J. A., Thamphiwatana, S., Dehaini, D., Gao, W., Zhang, K., Li, S., & Zhang, L. (2016) · Theranostics · doi:10.7150/thno.14471 · Cited by 251
Yohe, S. T., Colson, Y. L., & Grinstaff, M. W. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211148a · Cited by 248
Ma, A.-Q., Chen, H., Cui, Y., Luo, Z., Liang, R., Wu, Z., Chen, Z., Yin, T., Ni, J., Zheng, M., et al. (2018) · Small · doi:10.1002/smll.201804028 · Cited by 246
Self-citationHe, J., Li, C., Ding, L., Huang, Y., Yin, X., Zhang, J., Zhang, J., Yao, C., Liang, M., Pirraco, R. P., et al. (2019) · Advanced Materials · doi:10.1002/adma.201902409 · Cited by 248
Shinde, V. R., Revi, N., Murugappan, S., Singh, S. P., & Rengan, A. K. (2022) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2022.102915 · Cited by 261
Capretto, L., Carugo, D., Mazzitelli, S., Nastruzzi, C., & Zhang, X. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.08.002 · Cited by 250
Molecular imaging and therapy of cancer with radiolabeled nanoparticles
Hong, H., Zhang, Y., Sun, J., & Cai, W. (2009) · Nano Today · doi:10.1016/j.nantod.2009.07.001 · Cited by 248
Progress in material design for biomedical applications
Tibbitt, M. W., Rodell, C. B., Burdick, J. A., & Anseth, K. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516247112 · Cited by 244
Spring, B. Q., Sears, R. B., Zheng, L. Z., Mai, Z., Watanabe, R., Sherwood, M. E., Schoenfeld, D., Pogue, B. W., Pereira, S. P., Villa, E., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.311 · Cited by 243
Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
Abdalla, A. M. E., Xiao, L., Ullah, M. W., Yu, M., Ouyang, C., & Yang, G. (2018) · Theranostics · doi:10.7150/thno.21674 · Cited by 240
Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy
Yang, X., Dou, S., Sun, T., Mao, C., Wang, H., & Wang, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.07.035 · Cited by 242
Guo, H., Baker, A. L., Guo, J., & Randall, C. A. (2016) · ACS Nano · doi:10.1021/acsnano.6b03800 · Cited by 242
Self-assembling peptide-based building blocks in medical applications
Acar, H., Srivastava, S., Chung, E. J., Schnorenberg, M. R., Barrett, J. C., LaBelle, J. L., & Tirrell, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.08.006 · Cited by 244
Therapeutic Nanoparticles in Clinics and Under Clinical Evaluation
Schütz, C. A., Juillerat‐Jeanneret, L., Mueller, H., Lynch, I., & Riediker, M. (2013) · Nanomedicine · doi:10.2217/nnm.13.8 · Cited by 241
Therapeutic radionuclides in nuclear medicine: current and future prospects
Yeong, C. H., Cheng, M., & Ng, K.-H. (2014) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1400131 · Cited by 240
Designer Biomaterials for Nanomedicine
Doshi, N., & Mitragotri, S. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200901538 · Cited by 242
Current Advances in Polymer-Based Nanotheranostics for Cancer Treatment and Diagnosis
Luk, B. T., & Zhang, L. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am5036225 · Cited by 246
Zhang, Q., Wu, Z., Li, N., Pu, Y., Wang, B., Zhang, T., & Tao, J. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.03.196 · Cited by 239
A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer
Xiao, K., Luo, J., Fowler, W. L., Li, Y., Lee, J. S., Li, X., Cheng, R. H., Wang, L., & Lam, K. S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.015 · Cited by 238
Size and shape-dependent cytotoxicity profile of gold nanoparticles for biomedical applications
Woźniak, A., Malankowska, A., Nowaczyk, G., Grześkowiak, B. F., Tuśnio, K., Słomski, R., Zaleska‐Medynska, A., & Jurga, S. (2017) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-017-5902-y · Cited by 238
Phycocyanin: A Potential Drug for Cancer Treatment
Jiang, L., Wang, Y., Yin, Q.-F., Liu, G., Liu, H., Huang, Y., & Li, B. (2017) · Journal of Cancer · doi:10.7150/jca.21058 · Cited by 248
Drug Targeting via Platelet Membrane–Coated Nanoparticles
Wang, S., Duan, Y., Zhang, Q., Komarla, A., Gong, H., Gao, W., & Zhang, L. (2020) · Small Structures · doi:10.1002/sstr.202000018 · Cited by 244
Rhee, M., Valencia, P. M., Rodriguez, M. I., Langer, R., Farokhzad, O. C., & Karnik, R. (2011) · Advanced Materials · doi:10.1002/adma.201004333 · Cited by 236
Nanoparticle radio-enhancement: principles, progress and application to cancer treatment
Kuncic, Z., & Lacombe, S. (2017) · Physics in Medicine and Biology · doi:10.1088/1361-6560/aa99ce · Cited by 244
Kanapathipillai, M., Brock, A., & Ingber, D. E. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.005 · Cited by 234
Zhang, J., Yang, C., Zhang, R., Chen, R., Zhang, Z., Zhang, W., Peng, S.-H., Chen, X. S., Liu, G., Hsu, C., et al. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201605094 · Cited by 241
Getting Drugs Across Biological Barriers
Yang, R., Wei, T., Goldberg, H., Wang, W., Cullion, K., & Kohane, D. S. (2017) · Advanced Materials · doi:10.1002/adma.201606596 · Cited by 249
Additive Manufacturing of Precision Biomaterials
Guzzi, E. A., & Tibbitt, M. W. (2019) · Advanced Materials · doi:10.1002/adma.201901994 · Cited by 246
Lee, J., Chen, K., Noh, S., Garcia, M. A., Wang, H., Lin, W., Jeong, H., Kong, B. J., Stout, D. B., Cheon, J., et al. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201207721 · Cited by 234
Emerging roles of exosomal miRNAs in diabetes mellitus
He, X., Kuang, G., Wu, Y., & Ou, C. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.468 · Cited by 234
Biologically Responsive Polymeric Nanoparticles for Drug Delivery
Colson, Y. L., & Grinstaff, M. W. (2012) · Advanced Materials · doi:10.1002/adma.201200420 · Cited by 234
Pan, L., Liu, J., He, Q., & Shi, J. (2014) · Advanced Materials · doi:10.1002/adma.201402752 · Cited by 233
Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities
Claridge, B., Lozano, J., Poh, Q. H., & Greening, D. W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.734720 · Cited by 243
Advances of Cancer Therapy by Nanotechnology
Wang, X., Wang, Y., Chen, Z. G., & Shin, D. M. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.1.1 · Cited by 227
Self-citationRecent advances in curcumin nanoformulation for cancer therapy
Lee, W., Loo, C., Young, P. M., Traini, D., Mason, R. S., & Rohanizadeh, R. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.916686 · Cited by 232
Wrapping of nanoparticles by membranes
Bahrami, A. H., Raatz, M., Agudo‐Canalejo, J., Michel, R., Curtis, E. M., Hall, C. K., Gradzielski, M., Lipowsky, R., & Weikl, T. R. (2014) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2014.02.012 · Cited by 235
Equine Laminitis of Alimentary Origin: An Experimental Model
Garner, H. E., Coffman, J. R., Hahn, A. W., Hutcheson, D. P., & Tumbleson, M. E. (1975) · American Journal of Veterinary Research · doi:10.2460/ajvr.1975.36.04.441 · Cited by 229
Javanbakht, S., Pooresmaeil, M., & Namazi, H. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.12.066 · Cited by 229
The role of exosomal noncoding RNAs in cancer
Xie, Y., Dang, W., Zhang, S., Yue, W., Yang, L., Zhai, X., Yan, Q., & Lu, J. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0984-4 · Cited by 230
Halley, P. D., Lucas, C. R., McWilliams, E. M., Webber, M. J., Patton, R. A., Kural, C., Lucas, D. M., Byrd, J. C., & Castro, C. E. (2015) · Small · doi:10.1002/smll.201502118 · Cited by 225
Quinto, C. A., Mohindra, P., Tong, S., & Bao, G. (2015) · Nanoscale · doi:10.1039/c5nr02718g · Cited by 227
Collective fluorescence switching of counterion-assembled dyes in polymer nanoparticles
Reisch, A., Didier, P., Richert, L., Oncul, S., Arntz, Y., Mély, Y., & Klymchenko, A. S. (2014) · Nature Communications · doi:10.1038/ncomms5089 · Cited by 226
Expert opinion: Responsive polymer nanoparticles in cancer therapy
Liechty, W. B., & Peppas, N. A. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2011.08.004 · Cited by 232
Metadata
- Authors
- Davis, M. E., Chen, Z., & Shin, D. M.
- Affiliations
- California Institute of Technology (US)
- Emory University (US)
- Corresponding author
- Davis, Mark E.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-09
- Volume
- 7
- Issue
- 9
- Pages
- 771-782
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2082511916
- Cited by
- 4,233
- References
- 108
- Citations by year
- 2026: 68 · 2025: 134 · 2024: 165 · 2023: 143 · 2022: 171 · 2021: 217 · 2020: 224 · 2019: 260 · 2018: 316 · 2017: 340 · 2016: 364 · 2015: 383 · 2014: 385 · 2013: 332 · 2012: 268
- FWCI
- 7.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- National Cancer Institute (U54CA119338)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Keywords
- nanotherapeutics, cancer therapy, nanomedicine, targeted drug delivery, tumor localization, cellular uptake, clinical translation, clinical trials, anticancer agents, adverse drug reactions
- MeSH terms
- Animals, Antineoplastic Agents, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Neoplasms, Drug Delivery Systems, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review